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Intracellular redistribution of procaspases during TPA-induced differentiation of U937 human leukemic cells.
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TO THE EDITOR
Caspases are aspartate-specific cysteine proteases that play a central role in most apoptotic pathways. These enzymes are synthesized as inactive precursors (procaspases) which can be proteolytically processed into active tetramers and function in a proteolytic cascade. Various post-translational modifications of procaspases modulate their activity, including phosphorylation and nitrosylation. It was suggested that their subcellular localization could also regulate their activation. 1 Procaspases are mainly localized in the cytosol. However, a fraction of procaspase-3 was identified in the mitochondria, in a complex with Hsp60 and Hsp10. A substantial portion of procaspase-2 and -9 was also found in the intermembrane space of the mitochondria. 1 In addition, procaspase-2 was localized to the nucleus 2 and to the Golgi complex, 3 while procaspase-9 was identified in the nucleus. 6 During apoptosis, several active caspases migrate from one cell compartment to another, possibly to cleave specific substrates. 1 Aside from their role in apoptosis, caspases were recently found to be involved in cell differentiation. 4, 5 To determine whether the differentiation process could influence procaspase localization, we used the U937 human leukemic cells triggered to undergo macrophagic differentiation by exposure to phorbol esters. 6 After 72 h, more than 90% of cells demonstrate a differentiated phenotype (not shown). Four subcellular fractions were isolated from parental and TPA-treated cells. Their purity was assessed by immunoblotting using Abs against COX IV and histone H1 which are located to the inner mitochondrial membrane and the nucleus, respectively (Figure 1a) . The Bcl-2 protein, that was located to the nuclear envelope, the endoplasmic reticulum and the outer mitochondrial membrane was absent from the cytosol (Figure 1a) . Thus, isolated fractions were considered to be of sufficient purity for studying the distribution of procaspases by immunoblotting (Figure 1b) . The long isoform of procaspase-2 (48 kDa) was detected in the four cellular fractions from undifferentiated cells. TPA-induced differentiation was associated with a decreased expression of procaspase-2 in whole cell extracts (Figure 1b) . We did not detect any cleavage fragment, nor an increased cleavage activity of the caspase-2 substrate VDVAD-AFC (not shown), suggesting the lack of activation of the enzyme. Interestingly, when studied in cell fractions, expression of procaspase-2 decreased first in the mitochondria, then in the cytosol and the microsomes, while the enzyme accumulated in the nucleus (Figure 1b) . Independent immunoblot analysis of these fractions does not reflect the relative amount of enzyme in each compartment. Therefore, we also examined the cells by fluorescent microscopy, before and 48 h after the beginning of TPA treatment. This analysis confirmed that the pattern of procaspase-2 expression was modified by TPA-induced differentiation. The granular staining observed in the cytoplasm of undifferentiated cells suggested that a large percentage of the enzyme was inside the mitochondria, which was confirmed by colocalization studies. After 48 h of TPA exposure, we observed a more diffuse staining of the cytoplasm and an increased staining of the nucleus (Figure 1c) . In contrast, when using an anti-procaspase-3 Ab, the nuclear staining was not influenced by the differentiation process (Figure 1d ). Nuclear redistribution of procaspase-2 was previously shown to involve its prodomain and could require interaction of the protein with the adaptor molecule RAIDD. 2 Expression of the four other studied enzymes was poorly modified by TPA-induced differentiation when studied in whole cell extracts (Figure 1b) . Procaspase-6 (34 kDa) was the only proenzyme whose localization was limited to the cytosol. Procaspase-3 (32 kDa), procaspase-7 (35 kDa) and procaspase-9 (48 kDa) were detected in the mitochondria. Procaspase-7 was detected in the three other studied fractions. The anti-procaspase-9 Ab revealed a 30 kDa band that may correspond to procaspase-9b isoform. 7 During the differentiation process, expression of this endogenous inhibitor of caspase-9 decreased in the cytosol and mitochondria while procaspase-9 accumulated in the mitochondria and the nucleus (Figure 1b) . When U937 cells Procaspases labeled with 488-alexa-conjugated goat anti-mouse IgG Abs were assigned the color green, mitochondria labeled with Mito-Tracker were stained in red and nuclei labeled with Hoechst 33342 were stained in blue. Colocalization was studied by overlying procaspase and mitochondria staining. One representative of at least three independent experiments is shown. underwent differentiation, the three proenzymes (procaspases-3, Ϫ7 and Ϫ9) accumulated in the mitochondria (Figure 1b) . The mechanism by which some procaspases enter the mitochondria remains unknown. No consensus mitochondrial import leader sequence was identified in these enzymes and procaspases purified from the mitochondria did not demonstrate any proteolytic processing. These observations suggest that cofactors expressed in a differentiation-dependent manner could account for the subcellular redistribution of procaspases, eg the recently described protein TMS1 (for target of methylation-induced-silencing 1) could mediate the nuclear localization of procaspase-9. 8 Altogether, these results indicate that procaspase redistribution is associated with TPA-induced differentiation of U937 leukemic cells, suggesting that this model may be appropriate for studying the molecular mechanisms of the nuclear and mitochondrial import of procaspases. 
